Abstract
Objectives
To investigate the relation of demographic factors, medication and symptoms to health-related quality of life in patients with inflammatory bowel disease, and to identify patients in need of special support.
Methods
A questionnaire packet comprising the Inflammatory Bowel Disease Questionnaire (IBDQ) and the European Federation of Crohn’s and Colitis Associations’ (EFCCA) Survey Questionnaire was sent to 3,852 adult members of the Crohn and Colitis Association of Finland. IBDQ was used for measuring health-related quality of life (HRQoL), and the EFCCA questionnaire gave information about demographics, symptoms and medication.
Results
Altogether 2,386 questionnaires (62%) were available for analysis. Patients reporting symptoms affecting leisure activities or work had significantly lower total IBDQ scores (indicating worse HRQoL) than patients with less disturbing symptoms. Satisfaction with current therapy, female gender and age affected the scores. Subjects who had undergone surgery scored lower than those who had not. Patients currently receiving corticosteroids and newly diagnosed patients had lower scores than other patients.
Conclusions
In everyday practice, paying attention to and reducing patients’ symptoms and their impact on daily life is important when aiming at improving HRQoL. Special attention should be given to patients who have undergone surgery, and to newly diagnosed patients.
Similar content being viewed by others
Abbreviations
- CD:
-
Crohn’s disease
- EFCCA:
-
European Federation of Crohn’s and Colitis Associations
- HRQoL:
-
Health-related quality of life
- IBD:
-
Inflammatory bowel disease
- IBDQ:
-
Inflammatory Bowel Disease Questionnaire
- IC:
-
Indeterminate/unspecified colitis
- IPAA:
-
Ileal pouch-anal anastomosis
- UC:
-
Ulcerative colitis
References
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. Journal of American Medical Association, 273, 59–65.
Irvine, E. J. (2008). Quality of life of patients with ulcerative colitis: Past, present, and future. Inflammatory Bowel Diseases, 14, 554–565.
Palm, Ø., Bernklev, T., Moum, B., et al. (2005). Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. Journal of Rheumatology, 32, 1755–1759.
Bernklev, T., Jahnsen, J., Henriksen, M., et al. (2006). Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflammatory Bowel Disease, 12, 402–412.
Petrak, F., Hardt, T., Clement, N., et al. (2001). Impaired health-related quality of life in inflammatory bowel diseases. Scandinavian Journal of Gastroenterology, 36, 375–382.
Nordin, K., Påhlman, L., Larsson, K., et al. (2002). Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 37, 450–457.
Bernklev, T., Jahnsen, J., Lygren, I., et al. (2005). Health-related quality of life in patients with inflammatory bowel disease measured with the Short Form-36: Psychometric assessments and a comparison with general population norms. Inflammatory Bowel Disease, 11, 909–918.
Irvine, E. J., Feagan, B., Rochon, J., et al. (1994). Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology, 106, 287–296.
Casellas, F., Arenas, J. I., Baudet, J. S., et al. (2005). Impairment of health-related quality of life in patients with inflammatory bowel disease: A Spanish multicenter study. Inflammatory Bowel Disease, 11, 488–496.
Drossman, D. A., Patrick, D. L., Mitchell, C. M., et al. (1989). Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Digestive Diseases and Sciences, 34, 1379–1386.
Zahn, A., Hinz, U., Karner, M., et al. (2006). Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis. Inflammatory Bowel Disease, 12, 1058–1067.
Bernklev, T., Jahnsen, J., Aadland, E., et al. (2004). Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scandinavian Journal of Gastroenterology, 39, 365–373.
Guyatt, G., Mitchell, A., Irvine, E. J., et al. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96, 804–810.
Bernklev, T., Moum, B., Moum, T., et al. (2002). Quality of life in patients with inflammatory bowel disease: Translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scandinavian Journal of Gastroenterology, 37, 1164–1174.
Ghosh, S., & Mitchell, R. (2007). Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. Journal of Crohn’s and Colitis, 1, 10–20.
Haapamäki, J., Turunen, U., Roine, R. P., et al. (2008). Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey. Scandinavian Journal of Gastroenterology, 43, 821–830.
Casellas, F., López-Vivancos, J., Casado, A., et al. (2002). Factors affecting health related quality of life of patients with inflammatory bowel disease. Quality of Life Research, 11, 775–781.
Hjortswang, H., Jarnerot, G., Curman, B., et al. (2003). The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. European Journal of Gastroenterology and Hepatology, 15, 1011–1020.
Han, S. W., McColl, E., Barton, J. R., et al. (2005). Predictors of quality of life in ulcerative colitis: The importance of symptoms and illness representations. Inflammatory Bowel Disease, 11, 24–34.
Gibson, P. R., Weston, A. R., Shann, A., et al. (2007). Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn’s disease. Journal of Gastroenterology and Hepatology, 22, 1306–1312.
Watanabe, K., Funayama, Y., Fukushima, K., et al. (2006). Assessment of the Japanese Inflammatory Bowel Disease Questionnaire in patients after ileal pouch anal anastomosis for ulcerative colitis. Journal of Gastroenterology, 41, 662–667.
Thirlby, R. C., Sobrino, M. A., & Randall, J. B. (2001). The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Archives of Surgery, 136, 521–527.
Canavan, C., Abrams, K. R., Hawthorne, B., et al. (2006). Long-term prognosis in Crohn’s disease: Factors that affect quality of life. Alimentary Pharmacology & Therapeutics, 23, 377–385.
Rutgeerts, P., Geboes, K., Vantrappen, G., et al. (1990). Predictability of the postoperative course of Crohn’s disease. Gastroenterology, 99, 956–963.
Michelassi, F., Lee, J., Rubin, M., et al. (2003). Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis. A prospective observational study. Annals of Surgery, 238, 433–445.
Berndtsson, I., Lindholm, E., Öresland, T., et al. (2007). Long-term outcome after ileal pouch-anal anastomosis: Function and health-related quality of life. Diseases of the Colon and Rectum, 50, 1545–1552.
Lepistö, A., Luukkonen, P., & Järvinen, H. J. (2002). Cumulative failure rate of ileal pouch-anal anastomosis and quality of life after failure. Diseases of the Colon and Rectum, 45, 1289–1294.
Turina, M., Pennington, C. J., Kimberling, J., et al. (2006). Chronic pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: Effect on quality of life. Journal of Gastrointestinal Surgery, 10, 600–606.
Kuisma, J., Järvinen, H., Kahri, A., et al. (2004). Factors associated with disease activity of pouchitis after surgery of ulcerative colitis. Scandinavian Journal of Gastroenterology, 39, 544–548.
Feagan, B. G., Songkai, Y., Mohan, B., et al. (2003). The effects of infliximab maintenance therapy on health-related quality of life. The American Journal of Gastroenterology, 98, 2232–2238.
Feagan, B. G., Reinisch, W., Rutgeerts, P., et al. (2007). The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. American Journal of Gastroenterology, 102, 794–802.
Otley, A. R., Griffiths, A. M., Hale, S., et al. (2006). Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflammatory Bowel Disease, 12, 684–691.
Acknowledgments
Financial support for printing and mailing the questionnaires was provided by the Schering–Plough Corporation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haapamäki, J., Turunen, U., Roine, R.P. et al. Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res 18, 961–969 (2009). https://doi.org/10.1007/s11136-009-9514-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-009-9514-y